S. Lim, B. E. Muhs, S. G. Marcus, E. Newman, R. S. Berman and S. P. Hiotis, “Results Following Resection for Stage IV Gastric Cancer; Are Better Outcomes Observed in Selected Patient Subgroups?” Journal of Surgical Oncology, Vol. 95, No. 2, 2007, pp. 118-122. doi:10.1002/jso.20328
 S. Maekawa, M. Saku, Y. Maehara, N. Sadanaga, K. Ikejiri, H. Anai, H. Kuwano and K. Sugimachi, “Surgical Treatment for Advanced Gastric Cancer,” Hepatogastroenterology, Vol. 43, No. 7, 1996, pp. 178-186.
 F. Bozzetti, G. Bonfanti, R. A. Audisio, R. Doci, G. Dossena, L. Gennari and S. Andreola, “Prognosis of Patients after Palliative Surgical Procedures for Carcinoma of the Stomach,” The Journal of Surgery, Gynecology and Obstetrics, Vol. 164, No. 2, 1987, pp. 151-154.
 H. H. Hartgrink, H. Putter, E. Klein Kranenbarg, J. J. Bonenkamp and C. J. van de Velde, “Value of Palliative Resection in Gastric Cancer,” British Journal of Surgery, Vol. 89, No. 11, 2002, pp. 1438-1443. doi:10.1046/j.1365-2168.2002.02220.x
 S. Sakuramoto, M. Sasako, T. Yamaguchi, T. Kinoshita, M. Fujii, A. Nashimoto, H. Furukawa, T. Nakajima, Y. Ohashi, H. Imamura, M. Higashino, Y. Yamamura, A. Kurita and K. Arai, “Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine,” The New England Journal of Medicine, Vol. 357, No. 18, 2007, pp. 1810-1820. doi:10.1056/NEJMoa072252
 Y. Emi, M. Yamamoto, I. Takahashi, H. Orita, Y. Kakeji, S. Kohnoe and Y. Maehara, “Phase II Study of Weekly Paclitaxel by One-Hour Infusion for Advanced Gastric Cancer,” Surgery Today, Vol. 38, No. 11, 2008, pp. 1013-1020. doi:10.1007/s00595-008-3769-8
 W. Koizumi, H. Narahara, T. Hara, A. Takagane, T. Akiya, M. Takagi, K. Miyashita, T. Nishizaki, O. Kobayashi, W. Takiyama, Y. Toh, T. Nagaie, S. Takagi, Y. Yamamura, K. Yanaoka, H. Orita and M. Takeuchi, “S-1 plus Cisplatin versus S-1 Alone for First-Line Treatment of Advanced Gastric Cancer (SPIRITS trial): A Phase III Trial,” The Lancet Oncology, Vol. 9, No. 3, 2008, pp. 215-221. doi:10.1016/S1470-2045(08)70035-4
 A. Nashimoto, H. Yabusaki, S. Nakagawa, Y. Takii, Y. Tsuchiya and T. Otsuo, “Preoperative Chemotherapy with S-1 and Cisplatin for Highly Advanced Gastric Cancer,” Anticancer Research, Vol. 29, No. 11, 2009, pp. 4689-4696.
 Y. J. Bang, E. Van Cutsem, A. Fevereislova, H. C. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, J. Hill, M. Lehle, J. Rüschoff and Y. K. Kang, “Trastuzumab in Combination with Chemotherapy versus Chemotherapy Alone for Treatment of HER2-Positive Advanced Gastric or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomized Controlled Trial,” Lancet, Vol. 376, No. 9742, 2010, pp. 687-697. doi:10.1016/S0140-6736(10)61121-X
 J. K. Smith, J. S. Hill, S. C. Ng, T. P. McDade, S. A. Shah and J. F. Tseng, “Potential Benefit of Resection for Stage IV Gastric Cancer: A National Survey,” Journal of Gastrointestinal Surgery, Vol. 14, No. 11, 2010, pp. 1660-1668. doi:10.1007/s11605-010-1351-3
 T. Okuyama, D. Korenaga, K. Koushi, S. Itoh, H. Kawanaka, Y. Ikeda and K. Takenaka, “The Prognostic Significance of Chemotherapy for Stage IV Gastric Cancer Patients: A Single-Institution Experience,” Surgery Today, Vol. 41, No. 7, 2011, pp. 935-940. doi:10.1007/s00595-010-4403-0
 M. Iwahashi, M. Nakamori, M. Tani, H. Yamaue, S. Sakaguchi, M. Nakamura, K. Ueda, M. Ichiro, E. Nishio and H. Tanimura, “Complete Response of Highly Advanced Gastric Cancer with Peritoneal Dissemination after New Combined Chemotherapy of S-1 and Low-Dose Cisplatin: Report of a Case,” Oncology, Vol. 61, No. 1, 2001, pp. 16-22. doi:10.1159/000055347
 N. Yoshimizu, Y. Saikawa, T. Kubota, Y. Akiba, M. Yoshida, Y. Otani, K. Kumai, T. Hibi and M. Kitajima, “Complete Response of a Highly Advanced Gastric Carcinoma to Preoperative Chemoradiotherapy with S-1 and Low Dose Cisplatin,” Gastric Cancer, Vol. 6, No. 3, 2003, pp. 185-190. doi:10.1007/s10120-003-0239-2
 I. Yoshida, Y. Sakurai, Y. Komori, S. Tonomura, T. Masui, M. Shoji, Y. Nakamura, H. Imazu, I. Uyama and M. Ochiai, “Successful Downstaging by S-1 Based Chemotherapy Followed by Surgical Resections for Gastric Carcinoma with Extensive Distant Lymph Node Metastasis-Report of Two Cases and a Review of Cases with Surgical Resection after Downstaging by S-1 Based Chemotherapy,” Hepatogastroenterology Vol. 52, No. 63, 2005, pp. 978-984.
 T. Kanda, K. Yajima, S. Kosugi, T. Ishikawa, Y. Ajioka and K. Hatakeyama, “Gastrectomy as a Secondary Surgery for Stage IV Gastric Cancer Patients Who Underwent S-1-Based Chemotherapy: A Multi-Institute Retrospective Study,” Gastric Cancer, Vol. 15, No. 3, 2012, pp. 235-244. doi:10.1007/s10120-011-0100-y
 K. Oyama, S. Fushida, J. Kinoshita, I. Makino, K. Nakamura, H. Hayashi, H. Nakagawara, H. Tajima, H. Fujita, H. Takamura, I. Ninomiya, H. Kitagawa, T. Tani, T. Fujimura and T. Ohta, “Efficacy of Pre-Operative Chemotherapy with Docetaxel, Cisplatin, and S-1 (DCS Therapy) and Curative Resection for Gastric Cancer with Pathologically Positive Para-Aortic Lymph Nodes,” Journal of Surgical Oncology, Vol. 105, No. 6, 2012, pp. 535-541. doi:10.1002/jso.22125